Repro Med Systems Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 38.0% | 39.7% | 37.7% | 35.0% | 36.6% | 37.1% | 37.2% | 36.5% | 39.8% | 37.4% | 40.2% | 34.9% | 38.0% | |
| 62.0% | 60.3% | 62.3% | 65.0% | 63.4% | 62.9% | 62.8% | 63.5% | 60.2% | 62.6% | 59.8% | 65.1% | 62.0% | |
| 18.5% | 17.9% | 18.0% | 13.5% | 18.8% | 12.6% | 11.6% | 11.7% | 9.0% | 10.5% | 11.2% | 8.9% | 9.9% | |
| 66.0% | 69.8% | 65.4% | 63.1% | 62.7% | 65.9% | 61.9% | 52.8% | 57.6% | 55.4% | 55.9% | 49.3% | 54.4% | |
| 87.6% | 90.9% | 86.2% | 79.1% | 84.2% | 80.9% | 75.7% | 66.6% | 68.6% | 67.6% | 67.1% | 59.9% | 65.7% | |
| -25.6% | -30.6% | -23.9% | -14.1% | -20.8% | -18.0% | -12.9% | -3.1% | -8.3% | -5.0% | -7.4% | 5.2% | -3.7% | |
| -23.8% | -28.1% | -23.6% | -11.7% | -19.3% | -17.6% | -12.1% | -1.9% | -7.5% | -4.4% | -6.9% | 2.1% | -4.0% | |
| -4.3% | 75.8% | 2.3% | 0.0% | – | 0.0% | – | 0.2% | 0.0% | 0.0% | – | 0.0% | – | |
| -19.5% | -103.9% | -23.6% | -11.7% | -19.3% | -17.7% | -12.1% | -2.0% | -7.5% | -4.5% | -6.9% | 2.1% | -4.0% | |
| -20.7% | -24.9% | -20.8% | -9.1% | -16.5% | -16.9% | -9.8% | 0.2% | -5.5% | -2.8% | -5.2% | 3.9% | -2.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.